• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Insulet expands Pod recycling program across U.S.

December 15, 2025 By Sean Whooley

Insulet Omnipod 5 in focus on the arm
The Omnipod 5 worn on the arm. [Image courtesy of Insulet]
Insulet (Nasdaq:PODD) announced today that it expanded its U.S. Pod recycling program, now making it available to all U.S. customers.

The Pod recycling program, offered at no cost to customers, enables users to request a recycling kit online. This allows them to return their used Omnipods. Insulet then decontaminates the returned Pods before transporting them to a company specializing in recycling for electronics and medical products.

Acton, Massachusetts-based Insulet said the program helps minimize landfill waste and advance its commitment to circular solutions.

“Here at Insulet, our mission is to transform the lives of people with diabetes, and we are equally committed to creating a more sustainable future,” said Carolyn Sleeth, SVP and U.S. GM. “We are proud of the success achieved through our Massachusetts and California Pod recycling pilot programs, which began in 2022 and 2024, and we are excited to now offer Pod recycling to all U.S. customers, reducing waste and minimizing our environmental impact.”

Read more about Insulet, its technology, and the rest of the diabetes tech industry in our free Diabetes Technology Special Report.

U.S. customers can seamlessly request the recycling kit online. Insulet also has “Pod takeback” programs outside the U.S. in several international markets. These programs enable customers to request a takeback kit by contacting their local customer support team.

“Reducing waste is a key priority for our company, and I’m thrilled that our program is now available nationwide. We’ve made it easy for customers to help advance this objective of our Sustainability program and look forward to diverting millions more Pods from U.S. landfills,” said Lisa Brady, VP and Chief Sustainability Officer.

Omnipod 5, the company’s latest Pod system, represents the first FDA-cleared tubeless automated insulin delivery system. It communicates with a CGM to proactively correct for glucose highs every five minutes. The system also protect against lows with insulin dosing.

Insulet plans to continue enhancing the system and looking toward next-generation technologies. CEO Ashley McEvoy outlined some of the planned improvements in a recent interview with Drug Delivery Business News, while she and other Insulet leaders expanded on those plans during the company’s recent Investor Day event.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Insulet

IN CASE YOU MISSED IT

  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance
  • Medtronic moves to divest final stake in MiniMed
  • Dexcom adds former Stryker CFO to board

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS